Literature DB >> 15908529

MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.

Savannah C Partridge1, Jessica E Gibbs, Ying Lu, Laura J Esserman, Debasish Tripathy, Dulcy S Wolverton, Hope S Rugo, E Shelley Hwang, Cheryl A Ewing, Nola M Hylton.   

Abstract

OBJECTIVE: The purpose of this study was to assess the value of MRI measurements of breast tumor size for predicting recurrence-free survival (RFS) in patients undergoing neoadjuvant (preoperative) chemotherapy and to compare the predictive value of MRI with that of established prognostic indicators. SUBJECTS AND METHODS: The study included 62 patients undergoing neoadjuvant chemotherapy. The longest diameter and volume of each tumor were measured on MRI before and after one and four cycles of treatment. Change in diameter on clinical examination, tumor size at pathology, and the number of positive nodes were determined. Each measure of tumor extent was assessed for the ability to predict RFS.
RESULTS: Univariate Cox analysis showed initial MRI volume was the strongest predictor of RFS (p = 0.002). Final change in MRI volume (p = 0.015) was more predictive than change in diameter on MRI (p = 0.077) or clinical examination (p = 0.27). Initial diameter on MRI (p = 0.003) and clinical examination (p = 0.033), tumor size at pathology (p = 0.016), and number of positive nodes (p = 0.045) were also significantly predictive of RFS. Early change in MRI volume (p = 0.071) and diameter (p = 0.081) after one chemotherapy cycle showed trends of association with RFS. Multivariate analysis showed initial MRI volume (p = 0.005) and final change in MRI volume (p = 0.003) were significant independent predictors.
CONCLUSION: MRI tumor volume was more predictive of RFS than tumor diameter, suggesting that volumetric changes measured using MRI may provide a more sensitive assessment of treatment efficacy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908529     DOI: 10.2214/ajr.184.6.01841774

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  91 in total

1.  Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy.

Authors:  H J Shin; H H Kim; J H Ahn; S-B Kim; K H Jung; G Gong; B H Son; S H Ahn
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

2.  Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.

Authors:  Albert E Cerussi; Vaya W Tanamai; David Hsiang; John Butler; Rita S Mehta; Bruce J Tromberg
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2011-11-28       Impact factor: 4.226

3.  Emerging Breast Imaging Technologies on the Horizon.

Authors:  Srinivasan Vedantham; Andrew Karellas
Journal:  Semin Ultrasound CT MR       Date:  2017-09-13       Impact factor: 1.875

4.  Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer.

Authors:  Savannah C Partridge; Risa K Vanantwerp; Robert K Doot; Xiaoyu Chai; Brenda F Kurland; Peter R Eby; Jennifer M Specht; Lisa K Dunnwald; Erin K Schubert; Constance D Lehman; David A Mankoff
Journal:  J Magn Reson Imaging       Date:  2010-11       Impact factor: 4.813

5.  Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ.

Authors:  Anjali S Kumar; Daniel F Chen; Alfred Au; Yunn-Yi Chen; Jessica Leung; Elisabeth R Garwood; Jessica Gibbs; Nola Hylton; Laura J Esserman
Journal:  Am J Surg       Date:  2006-10       Impact factor: 2.565

6.  Accuracy of MRI volume measurements of breast lesions: comparison between automated, semiautomated and manual assessment.

Authors:  Marga B Rominger; Daphne Fournell; Beenarose Thanka Nadar; Sarah N M Behrens; Jens H Figiel; Boris Keil; Johannes T Heverhagen
Journal:  Eur Radiol       Date:  2009-01-22       Impact factor: 5.315

7.  Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging.

Authors:  Ka-Loh Li; Savannah C Partridge; Bonnie N Joe; Jessica E Gibbs; Ying Lu; Laura J Esserman; Nola M Hylton
Journal:  Radiology       Date:  2008-07       Impact factor: 11.105

8.  [Focal lesions in whole-body MRI in multiple myeloma : Quantification of tumor mass and correlation with disease-related parameters and prognosis].

Authors:  S C Brandelik; J Krzykalla; T Hielscher; J Hillengass; J K Kloth; H U Kauczor; M A Weber
Journal:  Radiologe       Date:  2018-01       Impact factor: 0.635

9.  Effect of the enhancement threshold on the computer-aided detection of breast cancer using MRI.

Authors:  Jacob E D Levman; Petrina Causer; Ellen Warner; Anne L Martel
Journal:  Acad Radiol       Date:  2009-06-09       Impact factor: 3.173

10.  Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy.

Authors:  Regine Choe; Turgut Durduran
Journal:  IEEE J Sel Top Quantum Electron       Date:  2011-12-02       Impact factor: 4.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.